O'Melveny represents in $816 million biotech deal between Medtronic, China Kanghui
Minneapolis-headquartered medical therapy company Medtronic Inc. announced Friday it's purchasing China Kanghui Holdings Inc., which manufactures hardware used in treatment of bone fractures, for $816 million in cash. O'Melveny & Myers LLP represented China Kanghui with a team led by partner Paul S. Scrivano - who...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In